Status:
COMPLETED
GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study
Lead Sponsor:
Heart Care Foundation
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Cardiac rehabilitation programmes are a proven treatment for individuals with recent myocardial infarction, resulting in reduced morbidity and mortality compared to usual care. Unfortunately, followin...
Detailed Description
Study partially sponsored by Società Prodotti Antibiotici
Eligibility Criteria
Inclusion
- Recent myocardial infarction (within 3 months after the index event)
- Standard rehabilitation program of 3-6 weeks performed
- Informed consent (obtained before any study specific procedure)
Exclusion
- Age \> 75 years
- Any condition that in the opinion of the investigator would jeopardize the evaluation of efficacy or be associated with poor adherence to the protocol;
- Presence of any non-cardiac disease (e.g. cancer) that is likely to significantly shorten life expectancy
Key Trial Info
Start Date :
December 1 2000
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
3200 Patients enrolled
Trial Details
Trial ID
NCT00421876
Start Date
December 1 2000
End Date
December 1 2005
Last Update
February 3 2021
Active Locations (74)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale San Donato
Arezzo, AR, Italy
2
Az Osp Giuseppe Moscati
Avellino, AV, Italy
3
Fondazione Salvatore Maugeri
Cassano delle Murge, BA, Italy
4
Ospedale Romano di Lombardia
Romano Lombardo, BG, Italy